{"name":"Tasly Pharmaceuticals, Inc.","slug":"tasly-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"immunology","drugs":[{"name":"T89 Low dose","genericName":"T89 Low dose","slug":"t89-low-dose","indication":"Angina pectoris","status":"phase_3"},{"name":"Compound danshen dripping pills","genericName":"Compound danshen dripping pills","slug":"compound-danshen-dripping-pills","indication":"Angina pectoris","status":"marketed"},{"name":"T89 capsule","genericName":"T89 capsule","slug":"t89-capsule","indication":"Angina pectoris","status":"phase_3"},{"name":"T89 high dose","genericName":"T89 high dose","slug":"t89-high-dose","indication":"Chronic stable angina pectoris","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"5LGr","genericName":"5LGr","slug":"5lgr","indication":"Type 2 diabetes","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Sanqi+Bingpian","genericName":"Sanqi+Bingpian","slug":"sanqi-bingpian","indication":"Angina pectoris","status":"phase_3"}]}],"pipeline":[{"name":"5LGr","genericName":"5LGr","slug":"5lgr","phase":"phase_3","mechanism":"5LGr is a small molecule drug that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"T89 Low dose","genericName":"T89 Low dose","slug":"t89-low-dose","phase":"phase_3","mechanism":"T89 is a traditional Chinese medicine compound that improves myocardial energy metabolism and reduces ischemic injury in cardiovascular disease.","indications":["Angina pectoris","Myocardial infarction","Heart failure"],"catalyst":""},{"name":"Compound danshen dripping pills","genericName":"Compound danshen dripping pills","slug":"compound-danshen-dripping-pills","phase":"marketed","mechanism":"Compound danshen dripping pills improve blood circulation and reduce blood stasis by promoting vasodilation and inhibiting platelet aggregation.","indications":["Angina pectoris","Myocardial infarction prevention","Coronary artery disease"],"catalyst":""},{"name":"Sanqi+Bingpian","genericName":"Sanqi+Bingpian","slug":"sanqi-bingpian","phase":"phase_3","mechanism":"Sanqi+Bingpian is a traditional Chinese medicine compound that has been studied for its potential anti-inflammatory and cardiovascular protective effects.","indications":["Angina pectoris"],"catalyst":""},{"name":"T89 capsule","genericName":"T89 capsule","slug":"t89-capsule","phase":"phase_3","mechanism":"T89 is a traditional Chinese medicine-derived compound that improves myocardial energy metabolism and enhances cardiac function through multiple pathways.","indications":["Angina pectoris","Myocardial infarction","Heart failure"],"catalyst":""},{"name":"T89 high dose","genericName":"T89 high dose","slug":"t89-high-dose","phase":"phase_3","mechanism":"T89 is a traditional Chinese medicine compound that improves myocardial energy metabolism and reduces ischemic injury in cardiovascular disease.","indications":["Chronic stable angina pectoris","Acute coronary syndrome","Heart failure"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOeHRtQWxOLXBoTGJpS0tEUFhpZjJpQ0MtUHYtdGVsRXFMX0lXdTlCcnlmaDQ5UnpDZU9XQ0JhWVZ3RV9YU0J6WXNNWTA2ZE5QZFNFd2pnM1l4LTBkZlZpNUdTWW8wX0RodDFXNTg5em1JWEVsZnZOUWJ5Wkh0MzdKREprODMtTkdsbG4yY193cDhRdVItSm8yM3dXWXNKZw?oc=5","date":"2026-04-01","type":"pipeline","source":"openPR.com","summary":"Donkey-Hide Gelatin Market Next Big Thing | Major Giants Baiyao, - openPR.com","headline":"Donkey-Hide Gelatin Market Next Big Thing | Major Giants Baiyao,","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQeWdlc21MNEw5YjhIXzZLMk9RaURROUpFS01ZX0ZWVG1LVEhWSDJ4Nmp2cEhGcklDUDU0dnA5c3RsUnFDU3I5QVdfWjJPSnNRblFWc3p6UElYT2szZHVjZnlJeVpJZF9XbHdxdWtRaDUxOTVRUFZXMWc0Zno4WC1ORWtpOXpzT3k4ZlQ5NHdPNnNwNnJ6dUEwX0JRejZzTmxlbUJCVFFwRERlR29GOS1jeDRJdzJOUQ?oc=5","date":"2026-02-11","type":"deal","source":"Caixin Global","summary":"Tasly’s U.S. Drug Push Falters as Partner Ends Development Deal - Caixin Global","headline":"Tasly’s U.S. Drug Push Falters as Partner Ends Development Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOWlVObG04V1hDdV9wemR1RnJoN1ZNX2o4MDU4V3NJSV9BZjhnOVdKWXRNQ3cyNVVRdU1ReVhmSjkyMVFrbHlHOUFXZjY0am8zVzh6ZHAxVHpiTUYzMXd1eDE0bXd6NTJ2ajlmaHRia29tLVd0R2pHd0g3azZtTWVFLTZVclhRVlJ6SkI3NE1BUkRIZXFoa1hFLXJHVk5UbWRmc0hZXzVWX0JTRV9uY1BPM1VxZHREbDBQZFd1WQ?oc=5","date":"2024-08-05","type":"pipeline","source":"Yicai Global","summary":"TCM Giant China Resources Sanjiu to Take Control of Peer for USD869 Million - Yicai Global","headline":"TCM Giant China Resources Sanjiu to Take Control of Peer for USD869 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxPS3V5dF93QVk2MXo3WEJjSFZZZWczam1qMkNGMTIzLVEyeHNKV0NyZGVwT29vbTU4TlNRM0NjQnBHWGlma3Z3aXhHVl9FWEFadXpQT2dUX0tWRmlOYlJsd3V3NTJYcnZBbjdQUFJyT1JGdkdxMHNxVE5TcEIyTno3eV83QXo4SzUzdmZjU09jVVFIYnVGX1JQdnZ0YkdlTXcyWDBybjM0VE5JaHctNXRndkpkNXFVXzA5SnE2UmtRb3ZQVkpOX2JjcEZ6Zk9OZGgxWTVxV2ZGdDhqdGg2RGtzTnFidmcxdw?oc=5","date":"2020-12-24","type":"pipeline","source":"PharmiWeb.com","summary":"The Traditional Chinese Medicine Market To Traverse The Exponential Growth Trajectory Between 2020–2 - PharmiWeb.com","headline":"The Traditional Chinese Medicine Market To Traverse The Exponential Growth Trajectory Between 2020–2","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQcEEzSW1zcWZLUXBPN2tYVUM3N1RjOUJEam1EYnZzQjN4eThvU3JVLUNEcFV5RURCX2Q2R0lidG5Tb1dVQjBpUWVUczh6UU1nUV9MX1F4UjVWZ2ZjR19Va3NZOXR2d3dQM21kT1pTdHpBa2VmaTdsQTB6d25acnlOekx1aVprRzhNVHdnUi1TZWp2cVdxdk95YjNLRGc2Ym1E?oc=5","date":"2019-06-26","type":"pipeline","source":"NAI500","summary":"Tasly Biopharma Files for Hong Kong IPO That Could Raise $1 Billion - NAI500","headline":"Tasly Biopharma Files for Hong Kong IPO That Could Raise $1 Billion - NAI500","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQbW02MnppanNXZkdoS25RRVpYT2tjbjhEQU5qWlVDb21wdzhEMkZUeUFkRlB5bmE2dVlKcnEzWjJzTTRRNVUyZkJEMElRLURyRkg2dzlGMmYzQTdpSUFrcjIzbkVHX0FuNVRfZ1E1TDhyOXVlRDZITENHZFpIVlVGcWxtWXJGLS11OHBPemtxYkJWVzh2NkVsaVBJejBoRXh5UXpNMGhjMmk2LWZTaElvbGh6NW9HS2RlQnl0cw?oc=5","date":"2018-01-26","type":"regulatory","source":"Caixin Global","summary":"U.S. Approval Offers Shot in the Arm to China’s Traditional Medicine - Caixin Global","headline":"U.S. Approval Offers Shot in the Arm to China’s Traditional Medicine","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOSVdSOEItOFBJWFdEUWNNX1MxSzcxWWR1dVR5YWpNQ2pGdzVFNVV3c3VMZ1JubHNWM1o3ZHRoWS1SaFBQWkYwWXhfbjY3ZnBValBZekxmTFhFWmNwS0FjOHpYUjQ1WG95SkoyQUlvOTNLaWoxX09JNDRYMVN3Vm9VdmZfSGFvV0ZVMndHVkNickJYSEJoSGtXekFhY19vY25sTzFuUTVaRmhwQklTUFJqM1YxbTdmdmNV?oc=5","date":"2017-11-29","type":"pipeline","source":"Herbalife Ltd. (HLF)","summary":"Herbalife Nutrition and Tasly Holding Group to Form HT Innovations LP in the United States as a Joint Venture - Herbalife Ltd. (HLF)","headline":"Herbalife Nutrition and Tasly Holding Group to Form HT Innovations LP in the United States as a Joint Venture - Herbalif","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTFA4NTNmTzY5eXlqM3V0RVNJcFg2MDcwVl94YjJMSkJ0MUdqTnBjODlzQngzQ2pjLXAxS01KX1VpVEZaVi1fWTZ3Z2syOHo3QXltaEdYRFhDOXI?oc=5","date":"2017-06-13","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Tasly Pharmaceutical Group Co., Ltd (600535.SS) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Tasly Pharmaceutical Group Co., Ltd (600535.SS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE0wR1ViZ0Z4OHpfOEU2UVJWX0o2UUlzZjFxV0E1OEVvZzItVVRTR1hXME9TNmx3QkVBUjM5UlhNNG1zVFVHaDBNU2tLYkFCdWU5YnhHX2pEeTNKR1dIV0JzQi10WmYyOU5RSXF0cGU1X0VOV28?oc=5","date":"2015-08-19","type":"pipeline","source":"China Daily","summary":"Getting TCM accepted in US - China Daily","headline":"Getting TCM accepted in US","sentiment":"neutral"}],"patents":[],"drugCount":6,"phaseCounts":{"phase_3":5,"marketed":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}